08:00 , Jan 14, 2013 |  BC Week In Review  |  Company News

Illumina, PerkinElmer, Verinata deal

Illumina will acquire prenatal testing company Verinata for $350 million, plus up to $100 million in milestones through 2015. Illumina will gain Verinata's verifi prenatal test , which is marketed in the U.S. to identify...
02:10 , Jan 8, 2013 |  BC Extra  |  Company News

Roche: Illumina acquisition 'off the table'

Illumina Inc. (NASDAQ:ILMN) fell $3.86 to $50.90 on Monday after Roche (SIX:ROG; OTCQX:RHHBY) said a deal to acquire the sequencing and microarray company is "off the table." The pharma declined to provide further details. In...
07:00 , Sep 24, 2012 |  BC Week In Review  |  Company News

BlueGnome, Illumina deal

Illumina acquired cytogenetic diagnostic company BlueGnome for an undisclosed sum. BlueGnome offers its CytoChip genomic-based test to screen for genetic abnormalities associated with developmental delay and complex leukemias. BlueGnome's 24sure test is a pre-implantation test...
07:00 , Jul 2, 2012 |  BC Week In Review  |  Clinical News

24sure: Phase II started

BlueGnome said investigators began a U.S. Phase II trial in about 200 patients to evaluate pre-implantation diagnosis using 24sure for single embryo in vitro fertilization. BlueGnome Ltd. , Fulbourn, U.K.   Product: 24sure   Business:...